Hypouricemic effects of yogurt containing Lactobacillus gasser PA-3 for patients with hyperuricemia and/or gout randomized, double-blind, placebo-controlled comparison study

Hypouricemic effects of yogurt containing Lactobacillus gasser PA-3 for patients with hyperuricemia and/or gout randomized, double-blind, placebo-controlled comparison study - A study on the effect of the yogurt containing Lactobacillus gasseri PA-3 on uric acid level.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021837

Enrollment

Registered

2016-04-08

Start date

2014-05-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperuricemia and/or gout

Interventions

A 100g Yogurt non-containing Luctobacillus gasseri PA-3 is give for 8 weeks A 100g Yogurt concentration Luctobacillus gasseri PA-3 give for 8 weeks

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: All of them have been treated for hyperuricemia and/or gout at the hospital of Tokyo Women's Medical University. They met the following criteria: 1.Subjects who aged twenty years. 2.More[0020]subjects who had been taking hyperuricemia drug. 3.Subjects who low possibility of developing gouty arthritis after cessation of the drug for twelve weeks or more.

Exclusion criteria

Exclusion criteria: 1.Subjicts with sever or progressive disorder. 2.Subjicts with not reasonable to discontinue the drug for hyperuricemia or gout. 3.Subjicts with routine use of health food. 4.Subjicts with food allergies. 5.Subjects who are judged ineligible by the principal investigator or subinvestigator.

Design outcomes

Primary

Measure	Time frame
Serum uric acid level or Serum uric acid concentration change	—

Countries

Japan

Contacts

Public ContactHisashi[0020]Nakayama

Tokyo Women's Medical University Institute of Rheumatology

yamanoka@ior.twmu.ac.jp03-5269-1711

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026